Lantern Pharma Inc. (Nasdaq: LTRN) Employee Directory

Biotechnology ResearchTexas, United States11-50 Employees

Lantern Pharma, Inc. is a clinical-stage biotechnology company focused on oncology, developing precision cancer drugs with novel mechanisms of action and reviving abandoned or failed cancer therapies using machine learning, genomic data, and precision oncology trials. The company relies on its RADR platform to address core challenges in oncology development: effectively stratifying patient populations for trials and clarifying mechanisms of action to suggest potent drug combinations. Its aim is to accelerate personalized cancer therapy development through AI-driven, genomics-based patient stratification.
Based in Dallas, Texas, Lantern Pharma serves pharmaceutical developers and clinical researchers working on oncology drug discovery and development. A recent milestone is FDA IND clearance for STAR-001, enabling a planned Phase 1 pediatric trial for CNS tumors, illustrating progress in advancing its pipeline.

Sign up for free to view info

Company overview Email format